Clinical Trial Update: Etanercept in Rheumatoid Arthritis and Vascular Inflammation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating etanercept for rheumatoid arthritis and vascular inflammation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis
• Vascular Inflammation

Drugs mentioned

• Etanercept (Enbrel) (Etanercept)

Snippet

Sponsor: Innovaderm Research Inc. | Conditions: Rheumatoid Arthritis, Vascular Inflammation | Phase 4 | Status: TERMINATED